Indian stocks: Visit www.stage2stocks.com →

NeuroOne Medical Technologies Corporation

Stage 4 · Declining · week 21

As of Oct 22, 2026, NeuroOne Medical Technologies is in Stage 4, the downtrend phase, now in week 21 (since May 26, 2026). It closed at $0.98, 83.4% below its 52-week high and below its 200-day average, which is falling.

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. More about the company

$0.98
+8.80% today
$8.9M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is NMTC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 20w
S4 21w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 13w → S1 5w → S2 8w → S3 8w → S4 3w → S3 1w → S4 20w → S1 9w → S4 8w → S1 2w → S2 8w → S3 3w → S4 10w → S1 11w → S2 8w → S3 4w → S4 5w → S2 9w → S3 1w → S4 6w → S1 2w → S4 21w current
Total tracked: 164 weeks across 22 stage runs.

NMTC among Medical Devices111th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…111NMTCStage 4 · wk 2111−26.9%
vs 52W High
-83.4%
$0.90 lo$5.89 hi
83.4% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 21
1w13w26w
Week 21, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-70.6%
200 DMA: $3.34 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.16x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-26.9%
3M
-48.4%
6M
-79.4%
YTD
-80.8%
1Y
-80.1%
Scan Membership
Breakout Watch
Latest: 2025-02-10
7 appearances in last 60 days. First seen: 2019-03-05.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 21 · Vol 1.16x
2026-10-21S4
Wk 21 · Vol 0.65x
2026-10-20S4
Wk 21 · Vol 0.08x
2026-10-19S4
Wk 21 · Vol 0.04x
2026-10-16S4
Wk 21 · Vol 0.25x
2026-10-15S4
Wk 20 · Vol 0.40x
2026-10-14S4
Wk 20 · Vol 0.14x
2026-10-13S4
Wk 20 · Vol 0.26x
2026-10-12S4
Wk 20 · Vol 0.10x
2026-10-09S4
Wk 20 · Vol 0.19x
2026-10-08S4
Wk 19 · Vol 0.77x
2026-10-07S4
Wk 19 · Vol 0.28x
Moving averages & range
50 DMA
$1.45
200 DMA
$3.34
52W High
$5.89
52W Low
$0.90
5D Low
$0.90
Resistance levels (recent highs)
20d High
$1.33
60d High
$2.18
120d High
$4.76
250d High
$5.89
Next resistance
+35.7%
to 20d High
ROE
-124.7%
Profit margin -59.7%
Dividend Yield
0.00%
P/B 2.3

NeuroOne Medical Technologies: quick answers

What stage is NeuroOne Medical Technologies in?

As of Oct 22, 2026, NeuroOne Medical Technologies (NMTC) is in Stage 4, the downtrend phase. It entered Stage 4 on May 26, 2026 and is in week 21. What the four stages mean

Is NeuroOne Medical Technologies in an uptrend?

No. NeuroOne Medical Technologies is in a Stage 4 downtrend. It trades 70.6% below its 200-day average, which is falling.

How far is NeuroOne Medical Technologies from its 52-week high?

NeuroOne Medical Technologies closed at $0.98 on Oct 22, 2026, 83.4% below its 52-week high of $5.89. Its 52-week low is $0.90.

How has NeuroOne Medical Technologies performed over the past year?

As of Oct 22, 2026, NeuroOne Medical Technologies is down 80.1% over the past year and down 80.8% so far in 2026.

Which sector and industry is NeuroOne Medical Technologies in?

NeuroOne Medical Technologies is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.